Most men suffering from the disease should keep prostate, says the author of a book on prostate cancer and treatment.
MARK SCHOLZ, M.D.
Of the total number of men diagnosed with prostate cancer, 91.5 percent retain their normal lifespan and die from natural causes, not oncological diseases. Thus, men with prostate cancer can not slow down, but slow down and develop a general plan that takes into account the standard of living and quality of life. Partial information-based treatment choices often lead to permanent recurrence.
The optimal treatment pathways are in the right order – assessment of the size, location and distribution of tumors – post-training. If men take the time to do their homework, most people know that they can keep their prostate, manage their cancer differently, and learn to live well.
STANDARDS AND EDUCATION BASIS
Randomness makes it possible to understand the importance of the disease, which can endanger life from fever. Of course, men should align the intensity of treatment with the aggressiveness of the disease. Mild illnesses are desirable for soft treatments. Aggressive cancer requires aggressive therapy. Affected by side effects such as malignant neoplasms and sexual dysfunction are unfavorable in the case of malignant neoplasms. On the other hand, it may be desirable to avoid adverse effects associated with life-threatening illnesses.
The key to the treatment of prostate cancer is the knowledge of a particular stage and class of the disease. This reduces the number of therapeutic options that allows men to bypass many non-essential information. It helps with any online research and facilitates the interview with physicians, allowing them to spend the most commonly used treatments at their particular stages.
REQUIRED AND REQUIRED FOR THE PROGRAM
In order to understand the period of prostate cancer, a person should be able to provide several information that can be found in his medical chart: size of the tumor; numerical examination results; indicates that the scanner's cancer extends beyond the prostate; The cancerous cell, also known as the Gleason mark, is an estimate of how healthy or malignant cells are seen under the microscope; and Prostate Specific Antigen (PSA) blood proliferation is a trend that increases with prostate cancer.
I have developed a short quiz that will help patients to identify the period of prostate cancer and how effective their treatment is. It is available online at keytopc.com or pcri.org and is the site of the Institute for Prostate Cancer Research, which I founded. Also, my latest My Book "Prostate Prostate Cancer: 30 Specialists Explains 15 Stages of Prostate Cancer". My quiz violates the aggressiveness of prostate cancer with the so-called five phases of the spleen. for each stage:
• Sky – low risk.
• Teal – intermediate risk.
• Mood is a high risk.
• Indigo is a recurrent disease.
• Royal – metastatic or hormone-resistant diseases.
Finding the Best Therapy
When the prostate cancer is known, patients and physicians can determine how dangerous the illness is and how zero is achieved in the most intelligent treatment. The treatment manages from active control to various therapeutic combinations – immunotherapy, hormonal therapy and / or radiotherapy implants for the treatment of lower-risk tumors for a more advanced or high-risk disease. Surgery may be recommended, but I think that in very exceptional circumstances, for example, men who are exposed to intermediate risk or patients with too much prostate gland radiation.
My book offers a wide range of information on the treatment options available to different patients in a language that is understandable to patients. The information is also available at pcri.org.
I look for men as much as possible to collect information and seek a doctor specializing in prostate cancer, and I urge you to understand the tender feelings of the illness. Men diagnosed with prostate cancer will take a long time to study all their options. If they have a clear understanding of what kind of modern, modern care they offer, they will be glad to know that there is no need for surgery.
MARK SCHOLZ, M.D., specializes in medical oncology and internal medicine, specializes in prostate cancer. Scholz is a medical director and prostate partner of Research Center for Prostate Oncology in the city of Marina del Rey, California. He wrote two books, "The Prostate Injury Attack" and "The Key to Prostate Cancer: 30 Specialists Explains 15 Stages of Prostate Cancer."